2.74
前日終値:
$2.75
開ける:
$2.7
24時間の取引高:
121.52K
Relative Volume:
0.12
時価総額:
$195.03M
収益:
-
当期純損益:
$-192.96M
株価収益率:
-0.8303
EPS:
-3.3
ネットキャッシュフロー:
$-167.04M
1週間 パフォーマンス:
+14.64%
1か月 パフォーマンス:
+7.87%
6か月 パフォーマンス:
+114.06%
1年 パフォーマンス:
+14.64%
Ventyx Biosciences Inc Stock (VTYX) Company Profile
名前
Ventyx Biosciences Inc
セクター
電話
(858) 945-2393
住所
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
VTYX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
VTYX
Ventyx Biosciences Inc
|
2.735 | 199.66M | 0 | -192.96M | -167.04M | -3.30 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
377.49 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
448.72 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
555.82 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
700.72 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
326.56 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-03-12 | アップグレード | Oppenheimer | Perform → Outperform |
2024-03-12 | アップグレード | Wells Fargo | Equal Weight → Overweight |
2023-11-07 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2023-11-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2023-11-07 | ダウングレード | Oppenheimer | Outperform → Perform |
2023-11-07 | ダウングレード | Stifel | Buy → Hold |
2023-11-07 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2023-06-14 | 再開されました | Credit Suisse | Outperform |
2023-03-21 | 開始されました | Wells Fargo | Overweight |
2022-12-19 | 開始されました | Goldman | Buy |
2022-11-17 | 開始されました | Morgan Stanley | Overweight |
2022-09-07 | 開始されました | Stifel | Buy |
2022-09-01 | 開始されました | H.C. Wainwright | Buy |
2022-05-09 | 開始されました | Credit Suisse | Outperform |
2022-03-31 | 開始されました | Canaccord Genuity | Buy |
2022-02-01 | 開始されました | Oppenheimer | Outperform |
2021-11-15 | 開始されました | Jefferies | Buy |
2021-11-15 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Ventyx Biosciences Inc (VTYX) 最新ニュース
Goldman Sachs Group Inc. Has $682,000 Stock Position in Ventyx Biosciences, Inc. $VTYX - Defense World
Analyzing recovery setups for Ventyx Biosciences Inc. investorsMarket Activity Recap & Verified Entry Point Signals - newser.com
Pallas Capital Advisors LLC Acquires Shares of 17,824 Ventyx Biosciences, Inc. $VTYX - Defense World
Signal strength of Ventyx Biosciences Inc. stock in tech scannersJuly 2025 Analyst Calls & Accurate Intraday Trade Tips - newser.com
Tools to assess Ventyx Biosciences Inc.’s risk profileMarket Growth Summary & Reliable Breakout Stock Forecasts - newser.com
Risk vs reward if holding onto Ventyx Biosciences Inc.Weekly Profit Analysis & Long-Term Safe Investment Plans - newser.com
Macro Review: Can Ventyx Biosciences Inc grow without dilution2025 Pullback Review & Accurate Buy Signal Alerts - khodrobank.com
Reviewing Aprea Therapeutics (NASDAQ:APRE) and Ventyx Biosciences (NASDAQ:VTYX) - Defense World
Historical volatility pattern of Ventyx Biosciences Inc. visualized2025 Risk Factors & Reliable Breakout Forecasts - newser.com
Sentiment analysis tools applied to Ventyx Biosciences Inc.2025 Performance Recap & Real-Time Buy Signal Notifications - newser.com
Aug Catalysts: How does Ventyx Biosciences Inc. correlate with Nasdaq2025 Stock Rankings & Real-Time Volume Analysis Alerts - خودرو بانک
Using economic indicators to assess Ventyx Biosciences Inc. potential2025 AllTime Highs & Low Drawdown Investment Ideas - newser.com
Bond Watch: Can Ventyx Biosciences Inc outperform in the next rallyMarket Performance Summary & Consistent Return Strategy Ideas - خودرو بانک
Insider Sell: What are Ventyx Biosciences Incs earnings expectationsEarnings Growth Summary & Free Expert Verified Stock Movement Alerts - خودرو بانک
What earnings revisions data tells us about Ventyx Biosciences Inc.July 2025 Technicals & Free Long-Term Investment Growth Plans - newser.com
Will Ventyx Biosciences Inc. outperform the marketEarnings Recap Summary & Reliable Price Action Trade Plans - newser.com
Aug Sentiment: Should I add AREB stock to my portfolioBull Run & Safe Capital Allocation Plans - khodrobank.com
What’s the recovery path for long term holders of Ventyx Biosciences Inc.Bull Run & Free Expert Approved Momentum Trade Ideas - newser.com
Using data models to predict Ventyx Biosciences Inc. stock movement2025 Fundamental Recap & Short-Term High Return Strategies - newser.com
Forecasting Ventyx Biosciences Inc. price range with options dataEarnings Risk Report & Detailed Earnings Play Strategies - newser.com
Aug Summary: Can Ventyx Biosciences Inc scale operations efficientlyMarket Performance Recap & Verified Technical Signals - خودرو بانک
Market Review: Is Ventyx Biosciences Inc stock a buy or sell2025 Year in Review & Smart Money Movement Alerts - خودرو بانک
Take Profit: Is Ventyx Biosciences Inc stock overvalued or fairly pricedDay Trade & Expert Curated Trade Ideas - خودرو بانک
Analyst Upgrade: How does Ventyx Biosciences Inc score in quality rankingsBreakout Watch & Weekly Sector Rotation Insights - خودرو بانک
Market Fear: Is Ventyx Biosciences Inc. benefiting from interest rate changesJuly 2025 EndofMonth & Momentum Based Trading Ideas - خودرو بانک
Rate Hike: Will Ventyx Biosciences Inc stock hit new highs in YEAR2025 Technical Overview & Low Drawdown Momentum Ideas - khodrobank.com
Risks Report: Does Ventyx Biosciences Inc have consistent dividend growthMarket Risk Summary & Safe Investment Capital Preservation Plans - خودرو بانک
Movement Recap: Is WESCO International Inc a good ESG investmentWeekly Trade Summary & Long Hold Capital Preservation Tips - خودرو بانک
Aug PostEarnings: Is CSTM stock a buy or sell2025 Investor Takeaways & AI Powered Buy/Sell Recommendations - خودرو بانک
Chart Watch: What are the analyst revisions for LSTAIs Addus HomeCare Corporation stock a good investment in YEARMarket Sentiment Review & Weekly High Conviction Ideas - خودرو بانک
Ventyx Biosciences Inc. stock trend forecastWeekly Stock Analysis & Verified Chart Pattern Signals - newser.com
Ventyx Biosciences Inc (VTYX) 財務データ
収益
当期純利益
現金流量
EPS
Ventyx Biosciences Inc (VTYX) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Mohan Raju | CEO AND PRESIDENT |
Mar 28 '25 |
Option Exercise |
0.00 |
11,844 |
0 |
2,303,540 |
Nuss John | CHIEF SCIENTIFIC OFFICER |
Mar 28 '25 |
Option Exercise |
0.00 |
4,531 |
0 |
469,113 |
Nuss John | CHIEF SCIENTIFIC OFFICER |
Dec 27 '24 |
Sale |
2.36 |
21,119 |
49,841 |
464,582 |
大文字化:
|
ボリューム (24 時間):